Beyond chemobrain: A stepwise approach to identifying cognitive impairment in non-CNS cancer survivors
The 22nd National Report on Clinical Trials of Medicinal Products published by the Italian Medicines Agency (AIFA) in July 2026 highlights contrasting trends in Italian clinical research.